2023
DOI: 10.1039/d3lc00678f
|View full text |Cite
|
Sign up to set email alerts
|

Optomicrofluidic detection of cancer cells in peripheral blood via metabolic glycoengineering

K. Mirkale,
S. K. Jain,
T. S. Oviya
et al.

Abstract: The currently existing label-based techniques for the detection of circulating tumor cells (CTCs) target natural surface proteins of cells and are therefore applicable to only limited cancer cell types. We...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 51 publications
0
1
0
Order By: Relevance
“…Early diagnosis of cancer has been an area of high-profile research. Emerging cancer detection technologies based on more accurate biomedical imaging [ 1 4 ], DNA mutation [ 5 ], epigenetic abnormality [ 6 , 7 ], or metabolic products [ 8 ] have been developed and evaluated. Of these, DNA methylation aberration of specific genes occurs during the cancerous initiation and multiple progression stages, which has been considered as promising targets for the development of powerful diagnostic, prognostic, and predictive biomarkers [ 9 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Early diagnosis of cancer has been an area of high-profile research. Emerging cancer detection technologies based on more accurate biomedical imaging [ 1 4 ], DNA mutation [ 5 ], epigenetic abnormality [ 6 , 7 ], or metabolic products [ 8 ] have been developed and evaluated. Of these, DNA methylation aberration of specific genes occurs during the cancerous initiation and multiple progression stages, which has been considered as promising targets for the development of powerful diagnostic, prognostic, and predictive biomarkers [ 9 11 ].…”
Section: Introductionmentioning
confidence: 99%